Postpartum hypertension may represent the continuation of an antenatal hypertensive
disease, or a disorder presenting de novo after delivery. Although its true
prevalence is difficult to ascertain, complications of severe postpartum hypertension
include stroke, eclampsia and death.
It is unclear whether women with antenatal hypertension, including preeclampsia,
should routinely receive postpartum antihypertensive therapy.
It is also unclear whether women with mild to moderate postpartum
hypertension should be treated. If so, it isnot known which drug is preferable.
Future studies of prevention or treatment of postpartum hypertension should
include maternal and neonatal relevant outcomes as well as side effects.